Spironolactone-Associated Decreased Libido

Mechanism and Frequency

Spironolactone's anti-androgenic activity is associated with decreased libido, which is a frequent side effect, particularly in men, due to its potent inhibition of testosterone and dihydrotestosterone binding to androgen receptors 1, 2, 3
The medication decreases testosterone production and potentially inhibits 5-alpha-reductase activity, leading to decreased libido alongside other sexual side effects including impotence in men and menstrual irregularities in women 1, 2, 3, 4

The British Society of Gastroenterology identifies decreased libido as one of the most frequent side effects of spironolactone in men with cirrhosis and ascites, occurring alongside impotence and gynecomastia 1, 2
In women treated for acne, the American Academy of Dermatology guidelines acknowledge spironolactone's anti-androgenic mechanism, but decreased libido is not prominently featured, with focus on menstrual irregularities, breast tenderness, and dizziness instead 3, 5, 6, 7
In ophthalmology, decreased libido is listed among the most common side effects of spironolactone for central serous chorioretinopathy treatment, alongside headache, diarrhea, fatigue, gynecomastia, and menstrual disruption 4

The severity and frequency of anti-androgenic side effects, including decreased libido, are dose-dependent, with higher doses carrying significantly increased risk of hormonal side effects 6, 7
Research demonstrates a higher incidence of gynecomastia at higher doses, with 52.2% incidence at 150 mg/day or more, compared to 6.9% at 50 mg/day 6, 7

The American Academy of Dermatology suggests starting with the lowest effective dose to minimize anti-androgenic effects, with 75-100 mg daily being as effective as 150-300 mg daily but with substantially fewer sexual side effects 6, 7, 8
Consider alternative aldosterone antagonists, such as eplerenone, which has reduced affinity for androgen and progesterone receptors, resulting in decreased incidence of sexual side effects compared to spironolactone 8
Potassium canrenoate may also reduce gynecomastia and have fewer sexual side effects 1, 2